Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
111 hedge funds and large institutions have $5.41M invested in Ampio Pharmaceuticals Inc. in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 26 reducing their positions, and 30 closing their positions.
1,280% more call options, than puts
Call options by funds: $207K | Put options by funds: $15K
13% less funds holding
Funds holding: 128 → 111 (-17)
38% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 26
43% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 30
76% less capital invested
Capital invested by funds: $22.8M → $5.41M (-$17.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$459K |
| 2 |
E
Ergoteles
New York
|
+$238K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$159K |
| 4 |
VF
Virtu Financial
New York
|
+$106K |
| 5 |
Morgan Stanley
New York
|
+$52.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.31M |
| 2 |
WIC
Willis Investment Counsel
Gainesville,
Georgia
|
-$976K |
| 3 |
State Street
Boston,
Massachusetts
|
-$698K |
| 4 |
Renaissance Technologies
New York
|
-$454K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$344K |
AMPE Hedge Fund Activity: Q2 2022 in Review
111 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2022, worth a combined $5.41M — down 76% from $22.8M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of AMPE and 17 opened new positions — a net loss of 13 holders — while 26 trimmed existing stakes and 16 added.
The largest buyer was Millennium Management, adding an estimated $459K. The largest seller was BlackRock, cutting an estimated $2.31M.
- 111 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2022, down from 128 in Q1 2022.
- Funds reported $5.41M of Ampio Pharmaceuticals Inc. stock for Q2 2022, down 76% quarter-over-quarter.
- 17 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2022 and 30 closed out, a net change of -13 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q2 2022 was Millennium Management, an estimated $459K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q2 2022 was BlackRock, an estimated $2.31M sold.
Based on aggregated 13F filings for Q2 2022.